USD10
NVCT Shares
About Nuvectis PharmaNuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
USD10
NVCT Shares
About Nuvectis PharmaNuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Stats
TRADING WINDOW
Closed
OPENS AT
Jul 17 at 1:30 PM GMT+0
MARKET CAP
$586.37M
OPEN PRICE
Not enough data
LOW (1Y)
$5.55
HIGH (1Y)
$29.28
LOW (24H)
$18.38
HIGH (24H)
$19.97
VOLUME (24H)
$178.86K
74.57%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $19.43 | |
1 Week | $18.78 | |
1 Month | $12.10 | |
1 Year | $7.80 |
Past performance is not a reliable indicator of future results.
Discover more
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.